GetSwift Announces the Resignation of Bane Hunter and Appointment of Joel Macdonald as Interim CEO
NEW YORK–(BUSINESS WIRE)–GetSwift Technologies Limited (“GetSwift” or the “Corporation”; NEO: “GSW”), a leading provider of…
NEW YORK–(BUSINESS WIRE)–GetSwift Technologies Limited (“GetSwift” or the “Corporation”; NEO: “GSW”), a leading provider of…
Generates solid sales and earnings growth, delivers good cash performance for 2021 Fourth Quarter 2021:…
Fourth Quarter 2021 Highlights Sales of $2.1 billion, up 46% year over year, up 13%…
Record annual sales, earnings and cash flow in 2021 4Q21 Sales of $424 million; EPS…
Establishes Celanese as the Preeminent Global Specialty Materials Company Acquisition expected to generate approximately…
Lenalidomide Sandoz is indicated for use in several critical haematology-oncology conditions, per latest ESMO guidelines1,4…
Oslo (Norway), 18 February 2022 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company,…
Pratteln, Switzerland, February 18, 2022 – Santhera Pharmaceuticals (SIX: SANN) announces full redemption of its senior…
Update on ongoing Dupixent® (dupilumab) chronic spontaneous urticaria Phase 3 program In a Phase 3…
CINCINNATI, Feb. 17, 2022 (GLOBE NEWSWIRE) — Blue Water Vaccines, Inc. (“BWV” or “Blue Water…
HOUSTON–(BUSINESS WIRE)–ConocoPhillips (NYSE: COP) today announced through its Australian subsidiary that it has completed the…
Intel details plans to lead in traditional markets, disrupt high-growth emerging markets. SAN FRANCISCO–(BUSINESS WIRE)–Intel…
INDIANAPOLIS–(BUSINESS WIRE)–Modular Devices Holdings, LLC (“Modular Devices”), a leading provider of mobile and modular medical…
New board members bring a wealth of financial, strategy and global health expertise NORTH BRUNSWICK,…
Continued pipeline progress with three potentially first-in-class product candidates Strong cash position with cash runway…
ORION CORPORATION INSIDE INFORMATION / STOCK EXCHANGE RELEASE 17 FEBRUARY 2022 at 23.32 EET Orion’s…
ORION CORPORATION PRESS RELEASE17 FEBRUARY 2022 at 23.32 EET Darolutamide plus androgen deprivation therapy and docetaxel…
TORONTO, Feb. 17, 2022 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos…
Ms. Jones, a veteran of the biotechnology and pharmaceutical industries, has served as an Executive Officer…